⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Modivcare sees $33,847 in stock purchases by major shareholder

Published 12/02/2024, 05:43 PM
MODV
-

FORT WORTH, Texas—Q Global Capital Management, L.P., a significant stakeholder in ModivCare Inc. (NASDAQ:MODV), recently acquired additional shares of the company's common stock. The transactions, disclosed in a Form 4 filing, show purchases totaling $33,847. The purchases come as ModivCare, with a market capitalization of $264 million, has seen its stock decline over 57% year-to-date, according to InvestingPro data.

The acquisitions took place over several days, with shares purchased at prices ranging from $17.74 to $17.75 per share. On November 27, 126 shares were acquired at $17.74 each. This was followed by the purchase of 198 shares on November 29 at $17.745 per share. The most substantial acquisition occurred on December 2, with 1,583 shares bought at $17.75 per share. The stock, which currently trades at $18.51, has shown strong momentum with a 5.8% gain over the past week.

These transactions bring the total shares owned by Q Global Capital Management to 1,921,633. The purchases were made under an investment management agreement with Q5-R5 Trading, Ltd. According to the filing, Q Global Advisors, LLC, Renegade Swish, LLC, and Geoffrey P. Raynor are associated with Q Global Capital Management, with disclaimers on beneficial ownership of the shares. For deeper insights into insider trading patterns and comprehensive financial analysis, investors can access the full ModivCare research report on InvestingPro.

In other recent news, ModivCare Inc. reported steady third-quarter results, with revenue reaching $702 million and an adjusted EBITDA of $43 million. This aligns with market expectations and showcases a 5% growth in the company's Personal Care Services segment, as well as operational improvements in the Non-Emergency Medical (TASE:PMCN) Transportation segment. Despite a net loss of $27 million, ModivCare has revised its adjusted EBITDA guidance for 2024 to between $170 million and $180 million. The company remains optimistic for 2025, projecting a 10% increase in adjusted EBITDA, driven by membership growth and new contracts. These are recent developments that reflect the company's resilience and strategic foresight as it navigates the evolving healthcare landscape. ModivCare is also working on amending its credit agreement and managing a contract receivable balance of $110 million. The company's CEO, Heath Sampson, has discussed strategic positioning and operational efficiency as key factors in navigating healthcare complexities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.